IMUX
Price:
$0.6883
Market Cap:
$67.93M
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpo...[Read more]
Industry
Biotechnology
IPO Date
2014-04-17
Stock Exchange
NASDAQ
Ticker
IMUX
According to Immunic, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.92M. This represents a change of -59.66% compared to the average of 81.60M of the last 4 quarters.
The mean historical Enterprise Value of Immunic, Inc. over the last ten years is 82.05M. The current 32.92M Enterprise Value has changed 3.91% with respect to the historical average. Over the past ten years (40 quarters), IMUX's Enterprise Value was at its highest in in the June 2018 quarter at 259.11M. The Enterprise Value was at its lowest in in the December 2022 quarter at -60635391.60.
Average
82.05M
Median
71.03M
Minimum
-60635391.60
Maximum
206.35M
Discovering the peaks and valleys of Immunic, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 209.89%
Maximum Annual Enterprise Value = 206.35M
Minimum Annual Increase = -143.16%
Minimum Annual Enterprise Value = -60635391.60
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 65.51M | 209.89% |
| 2023 | 21.14M | -134.86% |
| 2022 | -60635391.60 | -143.16% |
| 2021 | 140.49M | 24.30% |
| 2020 | 113.02M | 145.40% |
| 2019 | 46.06M | 45.07% |
| 2018 | 31.75M | -82.39% |
| 2017 | 180.26M | 135.50% |
| 2016 | 76.54M | -62.90% |
| 2015 | 206.35M | -58.05% |
The current Enterprise Value of Immunic, Inc. (IMUX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.67M
5-year avg
55.91M
10-year avg
82.05M
Immunic, Inc.’s Enterprise Value is greater than PMV Pharmaceuticals, Inc. (25.00M), less than Relmada Therapeutics, Inc. (291.98M), less than Acrivon Therapeutics, Inc. Common Stock (43.63M), less than Lite Strategy, Inc. (54.26M), greater than Repare Therapeutics Inc. (23.36M), less than Vaxart, Inc. (87.39M), greater than TScan Therapeutics, Inc. (-43127305.00), greater than Biomea Fusion, Inc. (31.03M), less than Cibus, Inc. (94.92M), greater than Adicet Bio, Inc. (26.86M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 25.00M | $68.11M | |
| 291.98M | $293.33M | |
| 43.63M | $76.05M | |
| 54.26M | $64.37M | |
| 23.36M | $95.84M | |
| 87.39M | $88.82M | |
| -43127305.00 | $61.86M | |
| 31.03M | $70.80M | |
| 94.92M | $84.86M | |
| 26.86M | $46.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Immunic, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Immunic, Inc. (IMUX)?
What is the 3-year average Enterprise Value for Immunic, Inc. (IMUX)?
What is the 5-year average Enterprise Value for Immunic, Inc. (IMUX)?
How does the current Enterprise Value for Immunic, Inc. (IMUX) compare to its historical average?